Pyxis Oncology Inc (NASDAQ: PYXS) Has Succeeded In Gaining Momentum In 2025, The Stock Is Down -27.56% YTD
Pyxis Oncology Inc (NASDAQ:PYXS)’s traded shares stood at 3.07 million during the last session, with the company’s beta value hitting 1.11. At the close of